Crossref
26-A-16763-ACC SAFETY OF OBICETRAPIB: AN INTEGRATED POOLED PHASE III SAFETY ANALYSIS
JACC · 2026-04 · 87 (13) · A213-A214
DOI: 10.1016/j.jacc.2026.02.528 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Adam J. Nelson und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nelson, A. J., Kastelein, J., Hsieh, A., Ditmarsch, M., Kling, D., Ortiz, N., Wicks, D., Davidson, M., & Nicholls, S. J. (2026). 26-A-16763-ACC SAFETY OF OBICETRAPIB: AN INTEGRATED POOLED PHASE III SAFETY ANALYSIS. JACC, 87(13), A213-A214. https://doi.org/10.1016/j.jacc.2026.02.528
Vancouver
Nelson AJ, Kastelein J, Hsieh A, Ditmarsch M, Kling D, Ortiz N, et al. 26-A-16763-ACC SAFETY OF OBICETRAPIB: AN INTEGRATED POOLED PHASE III SAFETY ANALYSIS. JACC. 2026;87(13):A213-A214. doi:10.1016/j.jacc.2026.02.528
BibTeX
@article{Nelson2026,
author = {Nelson, Adam J. and Kastelein, John and Hsieh, Andrew and Ditmarsch, Marc and Kling, Douglas and Ortiz, Nancy and Wicks, Douglas and Davidson, Michael and Nicholls, Stephen J.},
title = {26-A-16763-ACC SAFETY OF OBICETRAPIB: AN INTEGRATED POOLED PHASE III SAFETY ANALYSIS},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A213--A214},
doi = {10.1016/j.jacc.2026.02.528}
}
EUVIMED